Price target upside
ACADIA Pharmaceuticals Inc. - Common Stock Price Target Upside or Downside
ACAD price target upside based on the current price and analyst average.
Direct answer
ACADIA Pharmaceuticals Inc. - Common Stock's analyst target implies +13.8%.
The average target is $33.25 compared with a recorded current price of $29.21.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 7, 2026.
Verified data
- Current price
- $29.21
- Average price target
- $33.25
- High price target
- $45.00
- Low price target
- $17.00
- Target upside
- +13.8%
- Consensus rating
- Buy
- Analysts
- 20
- Evidence date
- August 7, 2026
- Valid through
- August 14, 2026